Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

LYELLYEL
5 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in LYELL IMMUNOPHARMA INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 107,570 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $1.5M as of 2026-Q2. The position was increased (+25.1% shares). LYEL represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.5M

Current Shares

107,570

Total Value Change

+$967,672

Total Shares Change

+46,067

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
107,570
+25.1%
$1.5M0.0%$14.05
31
2026-Q1
Increased
85,971
+0.6%
$1.7M0.0%$23.33
26
2025-Q4
Increased
85,423
+7.4%
$2.6M0.0%$31.59
28
2025-Q3
Increased
79,510
+29.3%
$1.3M0.0%$14.97
32
2025-Q2
New
61,503
-
$543,6870.0%$8.94
34

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used